USPUSP-NF
This is a preview of
USP-NF/PF content.
Subscriber?
Access here!
Not a subscriber?
Learn more!
Apremilast
C22H24N2O7S 460.50
Acetamide, N-​[2-​[(1S)​-​1-​(3-​ethoxy-​4-​methoxyphenyl)​-​2-​(methylsulfonyl)​ethyl]​-​2,​3-​dihydro-​1,​3-​dioxo-​1H-​isoindol-​4-​yl]​-;
(S)-N-{2-[1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxoisoindolin-4-yl}acetamide [608141-41-9]

BRIEFING

Apremilast. Because there is no existing USP monograph for this drug substance, a new monograph based on validated methods of analysis is being proposed.

  1. The liquid chromatographic procedure in the Assay and the test for Organic Impurities were validated using the Zorbax SB C-8 brand of column with L7 packing. The typical retention time for apremilast is about 7 min for the Assay and about 26 min for the Organic Impurities test.

  2. The liquid chromatographic procedure in the Limit of Apremilast R-Enantiomer test was validated using the ChiralPak AD brand of column with L51 packing. The typical retention time for apremilast-R-enantiomer is about 14.5 min.

Description and solubility information: White to pale yellow powder. Slightly soluble in alcohol and practically insoluble in water.

 (SM2: H. Ramanathan)

 Case ID—SUB-1898

USP REFERENCE STANDARDS FOR PURCHASE

USP Apremilast RS
USP Apremilast Related Compound A RS
This is a preview of
USP-NF/PF content.
Subscriber?
Access here!
Not a subscriber?
Learn more!